BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma A, Mah M, Ritchie RH, De Blasio MJ. The adiponectin signalling pathway - A therapeutic target for the cardiac complications of type 2 diabetes? Pharmacol Ther 2021;:108008. [PMID: 34610378 DOI: 10.1016/j.pharmthera.2021.108008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Peng J, Chen Q, Wu C. The role of adiponectin in cardiovascular disease. Cardiovasc Pathol 2023;64:107514. [PMID: 36634790 DOI: 10.1016/j.carpath.2022.107514] [Reference Citation Analysis]
2 Han W, Yang S, Xiao H, Wang M, Ye J, Cao L, Sun G. Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders. Int J Mol Sci 2022;23. [PMID: 36555264 DOI: 10.3390/ijms232415627] [Reference Citation Analysis]
3 Xu Y, Zhu H, Li W, Chen D, Xu Y, Xu A, Ye D. Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies. Pharmacol Ther 2022;240:108284. [PMID: 36162728 DOI: 10.1016/j.pharmthera.2022.108284] [Reference Citation Analysis]
4 Nehme R, Diab-Assaf M, Decombat C, Delort L, Caldefie-Chezet F. Targeting Adiponectin in Breast Cancer. Biomedicines 2022;10. [PMID: 36428526 DOI: 10.3390/biomedicines10112958] [Reference Citation Analysis]
5 Xia W, Li X, Wu Q, Xu A, Zhang L, Xia Z. The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.951381] [Reference Citation Analysis]
6 Dabravolski SA, Sadykhov NK, Kartuesov AG, Borisov EE, Sukhorukov VN, Orekhov AN. The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy. Int J Mol Sci 2022;23:7863. [PMID: 35887211 DOI: 10.3390/ijms23147863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]